搜索临床试验以:MEK 162 疗法或分子靶向疗法
总计5312个结果
-
Johns Hopkins UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)完全的
-
The First People's Hospital of LianyungangHengrui Yuanzheng Bio-Technology Co., Ltd.未知
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern Cooperative... 和其他合作者招聘中
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, Inc主动,不招人
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Washington State, Department...完全的
-
University Health Network, Toronto完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Rambam Health Care Campus完全的
-
Centre de Recherche de l'Institut Universitaire...CHU de Quebec-Universite Laval撤销
-
Cantonal Hospital of St. Gallen完全的
-
Guangzhou 8th People's HospitalSun Yat-sen University完全的
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Simon Fraser University主动,不招人
-
Imperial College LondonWellcome Trust招聘中
-
Shanghai Chest Hospital招聘中
-
University Hospital, Strasbourg, France未知Visual Cognitive Deficits法国
-
University of California, Los AngelesNational Institutes of Health (NIH)完全的
-
Taipei Veterans General Hospital, Taiwan完全的靶向治疗是否提高了不能手术的非小细胞肺癌伴脊柱转移的生存率?